The Medicine Maker has published its 2026 Power List, an annual recognition of 60 individuals across small molecules, biopharma and advanced medicines who are helping to translate the industry’s potential into reality. Honourees are nominated by the publication’s readership and selected by a panel of expert judges.
Ali Pashazadeh, CEO and Founder of Treehill Partners, has been named in the Biopharma category, one of twenty individuals recognised for their influence on the sector over the past twelve months. The listing reflects a sustained body of commentary in which Pashazadeh has argued that the majority of late-stage drug development failures stem from strategic and commercial missteps rather than the underlying science – the thesis at the heart of Treehill’s clinical development optimization work.
Read the full list on: https://themedicinemaker.com/power-list/2026/